Original ArticlePharmacognosy ResearchVol. 17 | Issue 2 | 2025 | pp. 638–644Open access
In vitro Cytotoxicity Evaluation of Hardwickia binata Roxbs against Human Breast Cancer Cell Line MCF-7 and Human Cervical Cancer Cell Line HeLa
- 1*,
- 1
- 1 Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Amravati Road, Nagpur, Maharashtra, INDIA.
Published in Pharmacognosy Research
Correspondence: Snehal Praful Shingade
Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Amravati Road, Nagpur, Maharashtra, INDIA.
Email: snehal9177@rediffmail.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Dec 5, 2024
- Accepted:
- Mar 28, 2025
How to cite
Shingade, S. P., & Kakde, R. B. (2025). In vitro Cytotoxicity Evaluation of Hardwickia binata Roxbs against Human Breast Cancer Cell Line MCF-7 and Human Cervical Cancer Cell Line HeLa. Pharmacognosy Research, 17(2), 638–644. https://doi.org/10.5530/pres.20252008
Abstract
Hardwickia binata belongs to the family Caesalpiniaceae is used traditionally folklore remedies for a variety of illnesses, such as fungus, gram-positive and gram-negative bacteria, cancer, diarrhoea, leprosy, worm infections, dyspepsia, leucorrhoea, chronic cystitis and gonorrhoea. In the present study the leaves of Hardwickia binata were treated to solvent extraction using ethyl acetate, chloroform, acetone, ethanol by soxhlet. The various solvent extract were investigated for the presence of phytochemicals such as phenolic substances, flavonoids, tannins, glycosides and proteins. The phytochemical were determined by conventional qualitative test and quantitative test like total phenolic, total flavonoid content. Antioxidant activity was done by different assay method using DPPH radical scavenging assay, nitric acid scavenging, reducing power assay method. Cytotoxicity efficacy was estimated using MTT assay method against human breast cancer cell line MCF-7 and human cervical cancer cell line HeLa. IC50 was calculated. This study showed that Hardwickia binata leaves may have potential to inhibit cancer cell growth in addition to focus on search of phytochemicals from leaves of Hardwickia binata roxbs due to their health promising effect including antioxidant and anticancer and can be used as leading drugs to treat cancer. The plant also has excellent antioxidant activity.
Keywords
Subject
Article metadata
| Title | In vitro Cytotoxicity Evaluation of Hardwickia binata Roxbs against Human Breast Cancer Cell Line MCF-7 and Human Cervical Cancer Cell Line HeLa |
|---|---|
| Authors | Snehal Praful Shingade; Rajendra Baliram Kakde |
| Affiliations | Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Amravati Road, Nagpur, Maharashtra, INDIA. |
| Corresponding author | snehal9177@rediffmail.com |
| Journal | Pharmacognosy Research |
| Volume / Issue | Vol. 17, Issue 2 (2025) |
Also in this issue
- A Comprehensive Review of Phytochemical and Pharmacological Appraisal of Cassia fistula Linn.pp. 326–347
- Phytopharmacological Insights into Ricinus communis: A Comprehensive Overviewpp. 348–357
- Exploring the Therapeutic Potential of Natural Products in Obesity Treatment: Molecular Mechanisms and Isolation Techniquespp. 358–369
- Unearthing the Modulatory Operations of Phytochemicals: A Reliable Framework for Therapeutic Approachespp. 370–379
- Recent Advances in Transdermal Drug Delivery System and its Utilization in Herbal Medicinespp. 380–384
Readers Also Viewed
Effect of the Fractions of Coccinia grandis on Ethanol- Induced Cerebral Oxidative Stress in Rats
M. Umamaheswari, T. K. Chatterjee
Jan 1, 2009
Phytochemical Screening and Antioxidant Activity Evaluation of Selected Philippine Fruit Peels and Pulps
Mildred Dagcuta Pates, Angelo Mark Po Walag, Romeo M. Del Rosario
Aug 17, 2026
Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Review
Jehath Syed, Christy Thomas, Bavneet Kaur
Oct 23, 2026